Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000442226 | SCV000515106 | benign | not specified | 2015-09-10 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000865804 | SCV001006825 | likely benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2024-01-19 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000442226 | SCV002051119 | likely benign | not specified | 2021-12-14 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001840501 | SCV002102010 | benign | Autosomal recessive limb-girdle muscular dystrophy type 2J | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001840502 | SCV002102011 | benign | Myopathy, myofibrillar, 9, with early respiratory failure | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001840503 | SCV002102012 | benign | Early-onset myopathy with fatal cardiomyopathy | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001840500 | SCV002102013 | benign | Tibial muscular dystrophy | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004530551 | SCV004118821 | uncertain significance | TTN-related disorder | 2023-08-23 | criteria provided, single submitter | clinical testing | The TTN c.25809G>A variant is not predicted to result in an amino acid change (p.=). This variant is predicted to possibly create an acceptor site within the exon (Alamut Visual Plus v1.6.1). To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.045% of alleles in individuals of African descent in gnomAD, which is likely too common to be a primary cause of an autosomal dominant disorder (http://gnomad.broadinstitute.org/variant/2-179580332-C-T). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |
Ce |
RCV003422392 | SCV004155251 | likely benign | not provided | 2023-02-01 | criteria provided, single submitter | clinical testing | TTN: BP4, BP7 |
ARUP Laboratories, |
RCV003422392 | SCV004562116 | likely benign | not provided | 2023-10-10 | criteria provided, single submitter | clinical testing |